
---------------------------------
The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System. |
---------------------------------

---------------------------------
Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information
---------------------------------
|
| |
 |
Pharmacist e-Link CE Spotlight |
 |
 |
Embracing Pharmacy Professional Services for Business Survival
This educational symposium will analyze recent trends in the community pharmacy marketplace and highlight the continued need for pharmacy business diversification. It will also provide insight and sample business plans from community pharmacy owners who have embraced pharmacy professional services to make their pharmacy grow – even in times of economic distress.
Supported by an educational grant from Merck. |

|
|

|
PARKINSON'S DISEASE: CURRENT CONCEPTS IN NEUROPROTECTION AND PROSPECTS FOR THE FUTURE
This activity is designed to present the current insights on neuroprotection in PD and how they may affect the future treatment of PD. The challenges surrounding the development of neuroprotective drugs will be discussed as will the candidate agents for neuroprotection and new approaches to identifying neuroprotective agents.
This activity is supported by an educational grant from Teva Pharmaceutical Industries Ltd. |

|
|

|
COPD: Putting Guidelines into Practice
Research has shown that the diagnosis and treatment of COPD can be improved in primary care. A recent study in the journal Preventive Medicine (March 2005) concluded that although primary care providers manage asthma patients using asthma guidelines, a great proportion of COPD patients are under-treated, mainly in the primary stages of the disease.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. |
| |
|
| |
Please click here to forward this newsletter to a friend |
|
|